Umer Raffat

Pharmaceuticals Specialty: M&A Activity Will Continue to Drive Investor Interest

Editors December 1, 2015

Carolyn Koo October 14, 2014

New York
1270 Avenue of the Americas, Suite 1100
New York, NY 10020
P: +1 212 224 3300

London
4 Bouverie Street
London EC4Y 8AX
P: +44 207 779 8888

Hong Kong
Unit 2488, 24/F
Lee Garden One,
33 Hysan Avenue
Causeway Bay, Hong Kong
P: +852 2912 8001

About Us

Leadership Team

Careers

II Press Room

Masthead

Thought Leadership

Display Advertising

Reprints

FAQs

Events Calendar

Memberships

Subscribe to Premium

Register for Free Account

Sign up for II newsletters

© 2025 Institutional Investor LLC. All material subject to strictly enforced copyright laws. Please read our Terms & Conditions, Modern Slavery Act Transparency Statement, Accessibility Statement and Privacy Policy before using the site.

4.12.03 build:2025-12-12 Login